Mold illness is among the most underdiagnosed conditions in modern medicine. Chronic Inflammatory Response Syndrome (CIRS) — the systemic inflammatory condition triggered by exposure to water-damaged buildings and the mold, mycotoxins, bacteria, and other biotoxins they produce — affects an estimated 24% of the population that carries the HLA-DR gene variants that make biotoxin clearance difficult. For these individuals, mold exposure does not resolve when they leave the building. The inflammatory cascade continues indefinitely until the biotoxin burden is addressed, and the resulting multi-system illness is so complex and so poorly understood by most physicians that patients average 12 years and multiple misdiagnoses before receiving accurate identification and treatment.
This is not about being allergic to mold. Mold allergy is a different, less severe condition involving IgE-mediated immune responses to mold spores. CIRS involves an innate immune system that cannot clear biotoxins combined with ongoing biotoxin exposure — the result is a chronic inflammatory state that affects the brain, lungs, immune system, hormonal regulation, mitochondria, and multiple organ systems simultaneously.
HOW BUILDINGS GET MOLDY AND WHY IT MATTERS
Mold requires three conditions to grow: moisture, a food source (organic material — drywall paper, wood, carpet, ceiling tiles), and the right temperature. Modern construction creates ideal mold conditions. Buildings are built to be airtight for energy efficiency — which prevents the drying of moisture intrusion. Drywall, the universal interior finish in American construction, is an excellent mold growth medium when wet. Flat roofs, poor flashing, plumbing leaks inside walls, condensation in HVAC ductwork, and flooding all introduce moisture into building cavities where it cannot dry.
The mold that grows inside walls and under floors produces mycotoxins — secondary metabolites that are the mold’s chemical defense mechanisms. These mycotoxins become airborne attached to mold spores and fragments, enter the building air, and are inhaled and ingested by occupants. They are also deposited on surfaces and on food. Mycotoxins include aflatoxins (produced by Aspergillus species, classified as Group 1 human carcinogens), trichothecenes (produced by Stachybotrys chartarum and other species, with documented immunosuppressive and neurological effects), ochratoxin A (produced by Aspergillus and Penicillium species, nephrotoxic and possibly carcinogenic), and dozens of others with varying toxicity profiles.
The EPA estimates that approximately 50% of U.S. buildings have had water damage significant enough to support mold growth. This figure, if accurate, means that half of American homes, schools, and workplaces are potential biotoxin exposure environments. Illinois has specific risk factors — flooding from the Mississippi and Illinois rivers, heavy agricultural irrigation, basements in clay soil with high water table, and the freeze-thaw cycle that stresses building envelopes and causes water infiltration.
CIRS — WHAT THE ILLNESS LOOKS LIKE
CIRS from water-damaged building exposure presents with a constellation of symptoms that spans multiple organ systems and mimics many other conditions. The symptom cluster documented by Dr. Ritchie Shoemaker — the physician who identified and characterized CIRS and developed the Shoemaker Protocol for treatment — includes: fatigue, weakness, post-exertional malaise, cognitive impairment (brain fog, memory loss, difficulty concentrating, word-finding problems), headache, light sensitivity, joint pain, muscle cramping, unusual pain, ice pick pain, numbness, tingling, shortness of breath, sinus congestion, chronic cough, abdominal pain, diarrhea, appetite changes, mood changes including anxiety and depression, temperature dysregulation, excessive thirst and urination, and static shocks.
The symptom cluster is non-specific, which is why it is so frequently misdiagnosed. Individual symptoms are attributed to fibromyalgia, chronic fatigue syndrome, anxiety, depression, sinus disease, irritable bowel syndrome, or multiple other conditions. The pattern of multi-system involvement, particularly the combination of cognitive symptoms with physical symptoms and the correlation with specific building exposures, is the diagnostic clue that points toward biotoxin illness rather than psychiatric origin.
The Visual Contrast Sensitivity (VCS) test — available free at survivingmold.com — is a validated screening tool for biotoxin illness. It measures the ability to detect contrast at low light levels, which is impaired by the neurological effects of biotoxins. A positive VCS test (failing the test) in a person with multi-system symptoms and potential water-damaged building exposure should prompt further evaluation.
TESTING YOUR ENVIRONMENT
Visible mold is obvious. Hidden mold — inside walls, under flooring, in HVAC ductwork, in crawl spaces and attics — is not. The smell of mold (musty, earthy, or chemical odor) is a more reliable indicator of hidden mold than visual inspection, because mold that has been painted over or is inside a wall cavity may not be visible but its volatile organic compounds and mycotoxins still enter the air.
ERMI (Environmental Relative Moldiness Index) testing — a DNA-based dust test that identifies and quantifies mold species in settled dust — is the most sensitive available test for mold in buildings. It identifies the specific species present, which matters because some species (Stachybotrys, Chaetomium, Aspergillus) produce more dangerous mycotoxins than others. ERMI test kits are available for $200-300 and can be ordered directly without a contractor. The Mycometrics laboratory is a reputable provider.
Air sampling (spore trap testing done by inspectors) is less sensitive than ERMI for detecting hidden mold and provides a snapshot of one moment rather than integrated dust accumulation. It is more useful for assessing post-remediation clearance than for initial screening.
REMEDIATION — WHAT WORKS AND WHAT DOES NOT
Bleach does not remediate mold. It kills mold on non-porous surfaces but does not penetrate porous materials (drywall, wood, grout) where mold grows into the substrate. Bleach also does not neutralize mycotoxins. Applying bleach to a moldy surface kills the surface growth while leaving the root structure (hyphae) intact in the material — the mold regrows. Painting over mold does not remediate it.
Proper remediation requires physical removal of mold-contaminated materials (cut out and dispose of affected drywall, remove contaminated insulation, replace flooring), correction of the moisture source that caused the growth, and cleaning of remaining surfaces with appropriate antimicrobial agents (hydrogen peroxide, enzymatic cleaners, or commercial products specifically tested for mycotoxin neutralization). The EPA and IICRC S520 standard provide guidance on remediation protocols. Large remediation projects (more than 10 square feet of affected area by EPA guidelines) should be performed by certified remediation contractors using containment procedures to prevent cross-contamination during remediation.
SUPPORTING YOUR BODY
The most important intervention for mold illness is removing the exposure. No supplement protocol overcomes ongoing biotoxin exposure. If a water-damaged building is identified as the source, reducing time in that environment and working toward remediation or relocation is the foundation of recovery.
Cholestyramine and other binders: The Shoemaker Protocol uses cholestyramine (a prescription bile acid sequestrant) as the primary mycotoxin binder — it binds biotoxins in the gut and prevents their reabsorption. For those pursuing natural alternatives or adjuncts: activated charcoal, bentonite clay, and modified citrus pectin have gut-binding capacity for some mycotoxins and are available without prescription. Chlorella is a binder for some heavy metals and toxins. These should be taken away from meals and supplements as they bind broadly.
Nasal rinsing: The nasal passages are the primary route of mold spore and fragment entry. Daily saline nasal rinse — or xylitol nasal spray, which has additional antimicrobial properties — mechanically clears the nasal passages. EDTA-containing nasal sprays are used in the Shoemaker Protocol specifically for cases where Marcons (multiple antibiotic resistant coagulase negative staph) colonization of the sinuses is identified as a complicating factor.
Antifungal herbs: Oregano oil, black seed (Nigella sativa), pau d’arco, berberine, and garlic have documented antifungal activity. These can support reduction of mold colonization in the gut (mold ingested in food or swallowed from nasal drainage can colonize the GI tract and contribute to ongoing mycotoxin exposure). They are adjuncts to, not replacements for, environmental remediation.
Liver support: Mycotoxins are processed through the liver. Milk thistle (silymarin) specifically has documented protective effects against mycotoxin-induced hepatic damage in research — it has been studied for aflatoxin protection particularly. Dandelion root and burdock root support broader liver detoxification capacity.
Glutathione support: Mycotoxins deplete glutathione, the liver’s primary antioxidant and conjugation agent. NAC, alpha-lipoic acid, and glycine (a component of glutathione) support glutathione synthesis. Liposomal glutathione supplementation provides the most bioavailable direct form.
Cross-reference: Know Your Air — Indoor Air Quality | Know Your Air — Building Your Air Protocol | Know Your Body | Herbal Remedies | Root Cellar
FROM THE WASTELAND
Leaf Juice — Wasteland Survival Series, Book 1
Antifungal herb preparations including oregano oil, pau d’arco, and black seed, and the liver support and gut binding herbs relevant to mycotoxin illness, have full preparation protocols in Leaf Juice.
Paperback | Kindle